A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merkel Cell Carcinoma
Related studies linked through entity extraction aliases.
MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation
- Status
- COMPLETED
- Phase
- PHASE2
F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
- Status
- COMPLETED
- Phase
- NA
IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Merkel Positron Emission Tomography (PET) Protocol
- Status
- COMPLETED
- Phase
- PHASE2
The Impact of Total Body Skin Examination on Skin Cancer Detection
- Status
- COMPLETED
- Phase
- NA
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
- Status
- COMPLETED
- Phase
- N/A
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2